BACKGROUND: The mechanisms underlying the effects of prolonged cold-ischemia storage on kidney allografts are poorly understood. METHODS: To investigate effects of cold ischemia on donor-reactive immune responses and graft pathology, we used a mouse kidney transplantation model that subjected MHC-mismatched BALB/c kidney allografts to cold-ischemia storage for 0.5 or 6 hours before transplant into C57BL/6 mice. RESULTS: At day 14 post-transplant, recipients of allografts subjected to 6 versus 0.5 hours of cold-ischemia storage had increased levels of anti-MHC class II (but not class I) donor-specific antibodies, increased donor-reactive T cells, and a significantly higher proportion of transplant glomeruli infiltrated with macrophages. By day 60 post-transplant, allografts with a 6 hour cold-ischemia time developed extensive glomerular injury compared with moderate pathology in allografts with 0.5 hour of cold-ischemia time. Pathology was associated with increased serum levels of anti-class 2 but not anti-class 1 donor-specific antibodies. Recipient B cell depletion abrogated early macrophage recruitment, suggesting augmented donor-specific antibodies, rather than T cells, increase glomerular pathology after prolonged cold ischemia. Lymphocyte sequestration with sphingosine-1-phosphate receptor 1 antagonist FTY720 specifically inhibited anti-MHC class II antibody production and abrogated macrophage infiltration into glomeruli. Adoptive transfer of sera containing anti-donor MHC class II antibodies or mAbs against donor MHC class II restored early glomerular macrophage infiltration in FTY720-treated recipients. CONCLUSIONS: Post-transplant inflammation augments generation of donor-specific antibodies against MHC class II antigens. Resulting MHC class II-reactive donor-specific antibodies are essential mediators of kidney allograft glomerular injury caused by prolonged cold ischemia.
BACKGROUND: The mechanisms underlying the effects of prolonged cold-ischemia storage on kidney allografts are poorly understood. METHODS: To investigate effects of cold ischemia on donor-reactive immune responses and graft pathology, we used a mouse kidney transplantation model that subjected MHC-mismatched BALB/c kidney allografts to cold-ischemia storage for 0.5 or 6 hours before transplant into C57BL/6 mice. RESULTS: At day 14 post-transplant, recipients of allografts subjected to 6 versus 0.5 hours of cold-ischemia storage had increased levels of anti-MHC class II (but not class I) donor-specific antibodies, increased donor-reactive T cells, and a significantly higher proportion of transplant glomeruli infiltrated with macrophages. By day 60 post-transplant, allografts with a 6 hour cold-ischemia time developed extensive glomerular injury compared with moderate pathology in allografts with 0.5 hour of cold-ischemia time. Pathology was associated with increased serum levels of anti-class 2 but not anti-class 1 donor-specific antibodies. Recipient B cell depletion abrogated early macrophage recruitment, suggesting augmented donor-specific antibodies, rather than T cells, increase glomerular pathology after prolonged cold ischemia. Lymphocyte sequestration with sphingosine-1-phosphate receptor 1 antagonist FTY720 specifically inhibited anti-MHC class II antibody production and abrogated macrophage infiltration into glomeruli. Adoptive transfer of sera containing anti-donor MHC class II antibodies or mAbs against donor MHC class II restored early glomerular macrophage infiltration in FTY720-treated recipients. CONCLUSIONS: Post-transplant inflammation augments generation of donor-specific antibodies against MHC class II antigens. Resulting MHC class II-reactive donor-specific antibodies are essential mediators of kidney allograft glomerular injury caused by prolonged cold ischemia.
Authors: C Wiebe; I W Gibson; T D Blydt-Hansen; M Karpinski; J Ho; L J Storsley; A Goldberg; P E Birk; D N Rush; P W Nickerson Journal: Am J Transplant Date: 2012-03-19 Impact factor: 8.086
Authors: A M K Kaul; S Goparaju; N Dvorina; S Iida; K S Keslar; C A de la Motte; A Valujskikh; R L Fairchild; W M Baldwin Journal: Am J Transplant Date: 2015-01-12 Impact factor: 8.086
Authors: Isabel Quiroga; Philip McShane; Dicken D H Koo; Derek Gray; Peter J Friend; Susan Fuggle; Christopher Darby Journal: Nephrol Dial Transplant Date: 2006-02-20 Impact factor: 5.992
Authors: G Einecke; B Sis; J Reeve; M Mengel; P M Campbell; L G Hidalgo; B Kaplan; P F Halloran Journal: Am J Transplant Date: 2009-11 Impact factor: 8.086
Authors: Serena M Bagnasco; Andrea A Zachary; Lorraine C Racusen; Lois J Arend; Naima Carter-Monroe; Nada Alachkar; Susanna M Nazarian; Bonnie E Lonze; Robert A Montgomery; Edward S Kraus Journal: Transplantation Date: 2014-02-27 Impact factor: 4.939
Authors: Grace W Wu; Jon A Kobashigawa; Michael C Fishbein; Jignesh K Patel; Michelle M Kittleson; Elaine F Reed; Krista K Kiyosaki; Abbas Ardehali Journal: J Heart Lung Transplant Date: 2009-03-14 Impact factor: 10.247
Authors: Abolfazl Zarjou; Lingling Guo; Paul W Sanders; Roslyn B Mannon; Anupam Agarwal; James F George Journal: Kidney Int Date: 2012-08-08 Impact factor: 10.612
Authors: Hidetoshi Tsuda; Nina Dvorina; Karen S Keslar; Jessica Nevarez-Mejia; Nicole M Valenzuela; Elaine F Reed; Robert L Fairchild; William M Baldwin Journal: Am J Pathol Date: 2022-04-29 Impact factor: 5.770
Authors: Shannon R Reese; Nancy A Wilson; Yabing Huang; Lucille Ptak; Kenna R Degner; Ding Xiang; Robert R Redfield; Weixiong Zhong; Sarah E Panzer Journal: Transplantation Date: 2021-07-01 Impact factor: 5.385